Inici › Malaltia de Crohn › Rhode Island › Providence
Assaigs clínics de Malaltia de Crohn a Providence, RI
12 estudis de Malaltia de Crohn busquen participants en centres de Providence i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
ReclutantFase 3
- University Gastroenterology - Providence - West River Street ( Site 5057), Providence
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
ReclutantFase 2
- University Gastroenterology - Providence - Staniford Street /ID# 280919, Providence
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
ReclutantFase 4
- University Gastroenterology, Providence
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 2/3
- University Gastroenterology, Providence
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 2
- University Gastroenterology Providence, Providence
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
ReclutantFase 3
- University Gastroenterology, Providence
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- University Gastroenterology-Site Number: 8400103, Providence
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
ReclutantFase 3
- University Gastroenterology - GI Alliance-Site Number: 8400103, Providence
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
ReclutantFase 4
- University Gastroenterology, Providence
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Reclutant
- Gastroenterology Associates, Providence
Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
ReclutantFase 4
- Rhode Island Hospital, Providence
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
ReclutantFase 2
- Mirador Therapeutics Selected Site, Providence
Assaigs de Malaltia de Crohn en altres ciutats
- New York City, NY35 estudis
- Cleveland, OH19 estudis
- St. Louis, MO19 estudis
- Boston, MA19 estudis
- Miami, FL19 estudis
- Orlando, FL17 estudis
- Houston, TX17 estudis
- Atlanta, GA17 estudis
- Tyler, TX16 estudis
- San Diego, CA15 estudis
- San Antonio, TX15 estudis
- Los Angeles, CA15 estudis
Altres estudis a Providence
- Càncer d'ovari15 estudis
- Càncer d'endometri14 estudis
- Obesitat14 estudis
- Càncer de pulmó de cèl·lules no petites12 estudis
- Càncer (tots els tipus)12 estudis
- Colitis ulcerosa11 estudis
- Càncer de mama11 estudis
- Leucèmia mieloide aguda10 estudis
- Càncer metastàtic9 estudis
- Sobrepès9 estudis
- Malaltia d'Alzheimer8 estudis
- Trastorn per consum d'alcohol (TCA)8 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.